All Access Articles |
- GNI Group Ltd. (2160) Reports 89.3% Operating Profit Decline | 2025-02-18 | UNITED STATES
- Gyre Therapeutics Appoints Ping Zhang as Lead Independent Director | 2025-01-06 | PHARMACEUTICAL
- Gyre Therapeutics CEO expects pivotal phase 3 trial results in 2025 | 2024-11-13 | PHARMACEUTICAL
- Gyre Therapeutics Reports Q2 Revenue Drop | 2024-08-13 | UNITED STATES